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55 pts with HOCM (24 men, 62 ,- 12 y). 4.5 t 2.5 ml ethanol were ,niected 
via a b~llloon cathot0r, $onal loft heart cathetonsahon, exerose nght heart 
¢athefensation, transoosophageal ochocard~ogrophy and 01Octrephys=0tOg~c 
testing were performed I:mtoro as well as 2 weeks and 7 months after =n- 
tontontton Clinical mtem~at~0n ~sobtained with 1t max of 22 mocth~ Malo~ 
results were a tm:lu¢fion of septal thicknes~ (from 22 t 3 to 10 = 2 mm), 
an elimination of outflow obstm~ion and a 1~"mm,e ot I011 v~ntricutar filling 
pressures desp~m a slightly rnduced eie~tmn fraction (from 071 • 9 to 068 
9), Peak CK-actIwlY rose to a mean value of 665 ± 4621U, There was no 
!ate death after hosl~tat demiss~on= 
feshn9 gla~mnt post,E~ g~aa~ent LVE~P 
I~',efom TASH (n = 55) 56 t 43 mmHo 140 *_ 53 mrnHo 16 ; ~, rnmH0 
after t0 mm~es tn = 33) 15 = 22 mmH 9 44 ~ 4~ mmHg 14 i ~ mrnHg 
~tter2weeks(n=31) t} t 17mmHg 33 • 38mmH9 12 t 3mmH 9 
~ttef 5mo~thS (n = 9| 2 ~ 4mmHa 19 ~ 32mmHg 13 ~ 3mmHg 
After 7 months NyHA,sIage impr~ed from 2 9 -.- 0,4 tO t 6 ~ 06, exercise 
tolerance hem 62 ~ ~71o 83 ~ 39 watts and pulmonary artery mean pressure 
from 43 t 7 to 33 ~ 8 mmHg at t~lenticat workloads. Permanent high-grade 
av-b~ock were observed in 12 pts and 3 pts with severe concomitant disease 
coula not be reSuscitated from d~fferent emergencies related to the potential 
of TASH ind,.med av.~rondl.¢Iion disfu~ances. 
Conclusion: TASH leads to a pronounced clincal and hemodynam~c im- 
provement that compare favorable with the resuils of surgical myeclomy 
However, =t should performed only in pts with severe symloms refractory to 
drug therapy, as an alternative to surgery 
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~ Intluence of DDD LV Parameters  in Pacing on 
Hyper t roph ic  Obst ruct ive  Card iomyopathy :  Results 
of  the  PIC Study 
J Xa~er. N. Aeblscher, L Kappenberger. The PIe Study Group, D~v~s~on f
Card~oteg~, Department ot Medicine, Un~ers~. Hospital Lausanne. 
S~t~z'erland 
The Europe3n mult~center prospective ram:fomised study (PIC Study) col. 
leered 83 pts severely symptomatic from HOCM and refractory or intolerant 
to Dn.~. All were prospectively equipped w~th a dual-chamber pacemaker 
and followed for one-year. They were randon',sed to ~ree rnonths each 
of actwe (DDDon) o~ inactwe IAAI30 = DDD~ff) DDD pacing in a blinded 
crossover study, followed by six months of permanent DDDon paong Sev- 
enty eight pts completed the study. In 53 of them. complete ECHO data 
were avmlable to the central core lab for screening and 1 year follow-up 
The following parameters obtained by 2DE t~ere measured by two inDepen- 
dent observers: en~astohc d~ameter (LVed). septal thickness (IVS) and 
postenor wall thickness (PWth). For all these patrents the evolu~on of maxn- 
mat pressure gradient (maxPG = mmHg) was assessed by Doppler in sinus 
ft~thm (SR) and DDD pacing (PM). 
Pre-¢mplant 1 Yea~ Follow-up p 
LVedlmm) 43 : 5 44 -. 6 - 0001 
IVS 22 "* 5 22 : 5 NS 
P~'Vth 11 : 2 11 : 2 NS 
MaxPG SR 64 : 27 40 : 27 0 001 
MaxPG PM 36 ; 20 26 : 19 - 0005 
Conclusions: According to these results, permanent pacing in HOCM 
significantly and persistently reduced subaortic pressure gradtent but does 
not influence wall thickness after a permanent pacing penod of six to rune 
months. However, there is a slight but significant increase in left ventncular 
end-diastolic diameter. 
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[-8--~- 1-~ Amiodarone  in the  Treatment  o f  Chron ic  Atr ial  
F ibr i l lat ion:  Resul ts  o f  a Random(sad ,  Contro l led  
S tudy  
NE. Igoumenidis, G.E. Kochiadakis. M.E. Marketou. M.C. Solomou, 
F.M Zambetakis, E.G. Zuridakis, P.E Vardas. Cardiology Dept., Heraklion 
University Hospital Crete, Greece 
Background: The efficacy and safety of amiodarone in the conversion of 
chromC ~trlal hbrlnatlon was investLC}at~ in a pro'~p~-ctvve tar~k~ .~3 
placebo~contrellod study 
Methods Of 67 consecutive pahent~ (32 men, mean age 64 ; g yeafsl 
w~th AF lasting . 3 weeks, 33 recmved am*edarone and 34 placebo Ba,'~tlr-,e 
chmcal ¢haracteflst(cs were ~lmltar m the ~v~ grOUpS, P~ r ~ , ~  to 
amtedarono began with intravenou~ 5 mg/kg body w~g~t over 15 ram, 
followed by t5 mg/kg body w~¢ght over 24 hours and then 400 me/day 0ra!ty, 
for 1 month Pts randomized tO placebo receweO an rdent~cat amoflnt of 
saline iv over 24 hours and then oral pl~ebo tot one month. 
Resptft~. Convem=on to ~inLIs rhythm w~ achieved in 16 (4848%) o! the 
33 ptS who r~eive~ am~odarone and m none of tt~ 34 in the placebo g~0up 
(p: • 0.00t), In the amiodarone group none of the pts Ce~nve~led tO sinue 
rhythm w!thin the first 24 hours Those who COnverted had smaller atna ~an 
those who did not (LA d(amefer: 41.9 ~: 7.2 vs 50.4 • 5.7 ram, p: ~ 0001) 
Se~, age, ventncular rate. left ventncular inie¢tmn tractiOn and the auralm~ 
ot ,~mal fibn!lation did not d~ter signit~:.antly Pelween patients who converled 
and those who did not. Treatment was d~Pcontmued m 1 pt (ammdarOne 
group) because el allergic reaction No s~De effects weva observed m the 
placebo group 
Conclusions Amlodarone, admmmtered orally, appears to be sate and 
effecbve In the termination of chronic atnal tibnllation Left atna~ d=~, ; i~ ,~ 
the sole mdependenl predictor of conversmn 
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~ T h e  Influence of Age and Gender on Rats and 
Duration of Paroxysmal  Atrial  F ibr i l lat ion 
K Hnatkova. JEP.  Waklare. FD. MurgatreyD. X Guo, A.J C~,mm, 
M Malik St George'~ HOSprtE_ tA#_-~tcal School, London, Er.31and 
The influence of age and gender on paroxysmal atnal fibnllahon (PAF) is 
prewously undocumented 
Methods: The heart rate (HR) Dunng PAF in pts on no anfl-arrhythmve or 
rate limiting therapy was analysed Data were oblamed from the database 
of 177 24-hour Holier recordings whvch had been anatyseD to mark the 
onset anti termination of PAl=, and conveded into RR interval files. Only PAF 
episodes of at least 2 mm duralion containing ~20% noise were included. HR 
in the first 30 soc segment, HR in the rema~der el PAF. and the duration of PAF 
episodes were compared between age and sex different groups (Wilco*on 
test) 
Results 236 episodes from 55 reCOrdings m 32 pts (All pts: Bt 4 = 12 8 
years; male 119): 58.5 ~ 17.6 years: female (13): 655 ± 12.4 years) fulfilled 
the inclusion cntena Women were shghtly older than men (p = ns) The 
tal:}le dluStrafes the influence ot age and gender on heart rate dunng AF 
and duration of episodes All compansons of HR for age and gender were 
slgnlhcant (p - 0 05) 
HA tn l St 50 sE~ HR in remainder Duration ot PAF episode5 
cl PAF of PAF - median 
(mean : SD) [bpm i (mean ~ SD) (bpmJ (mean : 5D) [r~rt] 
~laie 1149 ~ 199 1110:202 801S05 t 17161 
Female 122 7 ~ 34 5 119 2 : 32 6 10 8 (89 8 : 2377) 
Ac~e mean 1121 .* 223 1084 -. 179 99(838 t 23201 
Age mean 120 1 : 2.53 1162 t 256 7 1 (469 ~ 137 I) 
Conclusion. PAF episodes are associated with faster heart rates and last 
longer cn women, which may reflect diffenng autonomfc resl~onSos to AF 
A slower ventncular rate dunng PAF in older patients probably reflects an 
increasing prevalence of impaired amovenmcular conduct=on 
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~-6~ Diurnal  F luc tuat ions  in the Mode o f  the  Onset of 
Paroxysmal  Atr ia l  F ibr i l lat ion 
K Hnatkova. J E P Wakfare. F O Murgetreyd. B Xre. A J C~mm. M Malik 
St Georges Hosprtal Medrc.:d SchoOl. London, England 
A central role for autonomic tone vn the onset el paroxysmal ~tnal fibnnatton 
(PAF) has been postullated Th~5 was ,nvest=gated by companng the onset 
Ot episodes begmnmg at night vs day 
Methods: A database of 177 24-hour Holter recordings from 60 pts (35 
male: mean age 61.7) sufferonng from PAF were recorded as a part of 
CRAFT teals. All episodes ~30 sec AF with I rain of noise free preceding 
sinus rhythm were identified. ~nd classified as day (8:00 am-lO:O0 pro) or 
night 110:00 pm-8:00 am) Mean hearl rate (HR) and change in HR (HR 
dunng final 30 sac vs final minute peer AFt were calculateD, as was the 
pattern of terminal beats before AF onset. Beats were classified as short (St. 
long (L), or normal (N) with N being defined as a doratTon betw'een 80% and 
120°,o of the median of the previous 10 beats. Sequences of three hnal beats 
before AF were found, and their prevale'~ce calculated. 
184A ABSTRACTS - Oral JACC Fehrear)' 1998 
Results: There WGS a total of 296 qualifying episodes of AF from 42 
recordings, The table summarlsos the comparisons between day and night- 
time episodes, HR prior AF was slower (p < 0,0001; WIIcoxon test) during 
the night, but other differences were non-significant, 
Comp~lrmon between mode of AF on~ot nt night and during day 
Number Mean HR A mann HR 'NNN' 'NSN' 'NL~' 
D~,, t31 75,0 bpm ,oO,1% 77,i% 2,~% 2,3% 
N igh~ 105 02,2 bpm ~G,3% 0?,0% 0.7% 3,0% 
Concl~ston: Apart from underlying HR, the mode el AF initiation does not 
differ during ~ympathetlG and parasympathetic predominance, 
9:15 
~ Pravalan©o f the 8ympathetle Influence Before 
Atrial Fibrillation Onset In the So-Called "Vagal 
Paroxysmal Atrial Fibrillation Patients" 
A, Capu¢cl, G, Coccngna t , A, Santarelll, S, Baulso, G, Borlant, Cardiology 
Co, of, G~ne~l Hospital Pla~nza, Italy; t testtf~te of Ne~tmtegy of Bolc~jna, 
In~tlftJte of Ca~tolngy Bologna, ~ Italy 
To evaluate the Influence of the autonomic nee/age eyBtom (ANS) on perex. 
ysmat ~trlal fibrillation (PAF) onset in putlonte (pte) wtth either n~tum:tt or 
"vaunt p~ttam", we studied 45 pie with a poligmphlo analyeie of steep and 
Halter monitoring after a complete druga wash.out, We ueod a Marquette 
sarlea 8000 Hotter with heart rate variability (HRV) software and defined the 
low freqoenglos (LF) (0,04-0,15 Ha) and high frequencies (HF) (0,15-0,40 
H~) ratio for all the sloop stages and at the PAF enact (tO mtmffea before), 
Spectral mo~sures wore comp~ted over 2 minutes e~mplee, 25 pts had no 
~trial fibrillation eptsodss, 5 pts had continues atrial fibrillation rhythm, Tee 
15 pts with docomonted PAF onset were selected for power spectral enaiysis 
of the Hotter recordings. 
W~lko Ph~o 1 -~ Phase 3-4 REM 
• LF/HF 214 t 0,e3" aUG 1: 010" 1 01 t 0 42' 1 52 !: 0 38 
• LF/HF st PAF onset 1 85 t O,5S 1 41 t 0,2~1 ~ 216 ~t 030 1 54 t 0 58 
• n PAF on~M 14 12 ~ 3 
• ~ p - 0 ,0001 vs 1--2 and 3--4; " ~ p • 00001 vs REM~ ' ~ p. 0 0OS v.~ REM ~ = p.  
O 0001 vs bssnl 
In conclusion, pts with apparent "vngal pattern" of PAF present a regular 
prevalence of the sympsthetlc and parasympathetic omponents during the 
different sleep stages. A sympathetic influence before PAF onset is prevalent 
expcclally during the superficial sloop phase 1-2, 
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~3--6-5--I Atrial Arrhythmlas Early After Cardloverslon Predict 
Recurrence of Atrial Fibrillation 
TIN, Maounis ~ , E, Kymzi t , E, Evgenladou ~ , K, Katsares ~ , E. Biltanou °, 
V, VasstllkosL A, Mnnolis ~ , D,V, Cokkinos ~ . 1st Cardiology Department, 
Greece; ~Onassis Cardiac Surgery Center, Greece: "~ Tzanio Hospital, 
Athen.~ Greece 
Background, The recurrence of atrial fibrillation (AF) alter electrical cardiover- 
ston (ECV) is frequent and affected by many factors, We assessed whether 
tho atrial ectoptc activity found in a Halter recording (HR) immediately after 
ECV for AF is predictive of future recurrence of this anhythmta. 
Methods: A total of 53 patients (pta) (31 mates, mean age 58 ± 12) with 
AF of varying duration and etiology, underwent a 24 hour HR immediately 
alter successful ECV. All had undergone an echocerdiogrephic evaluation to 
estimate left atrial size (LA), They were followed for one year after EC, on the 
same medication that they were receiving at the time of ECV (amiodarone 14, 
Prepafenone: 16, both: 12, sotalol: 11). From the HR the total number of atrial 
premature cemptexos (APCs) of the first six hours (6HAPs) end the average 
number of APCs per hour of the whole recording (HAPCs) were calculated 
and for statistical analysis their natural logarithms (In) wore computed. The 
endpoint o! the study was recurrence of the errhy~hmla t one year. 
Results: A total of 25 pts (47%) had AF recurrence at one year, Signifi- 
cant differences were found in the comparison of In6HAPCs and [nHAPCs 
between the two groups, while left atrial size (LA) or medication were not 
significantly differeht, 
AF roc, LA HAPCs (; \PCs In6APCs InHAPCs 
Yes 4.86 ~ 0,7 55~ 113 393 ~854 5,0~ 1.3 30 ~.- 13 
No 5.06 L 0.9 6 ~: 5 42 i 40 33 L 1 2" 1.4 ~: 1.1" 
'p - 0.0001 
The recording of 10 APCs per hour in the HR after ECV had a sensitivity 
of 70%, a specificity of 77%, a positive predictive value of 70% and negative 
predictive value of 77% for recurrence of AF in the first year after ECV. 
Conclusion: The number of APCs in n HR ¢tfter ECV for AF can Identify 
pts at high dek for recurrence of AF who might need optimization or change 
of treatment, oven before discharge, and more careful follow-up 
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~ Identlfloatlon of Hypertensive Patients With Atrial 
Fibrillation: Loft Atrial Size, Signal Averaged 
P-Wave, or Beth? 
A, Votgmon, S,L, Pinskl, S, Furmanov, P,A, S,ntoccL R,G, Tmhman, 
Rush.Presbyterian.St, Lc/ko~, Mr~l/cal Center, Chicago, IL, USA 
Background: Hypertension Is the most common cause o! atrial fibrillation 
(AF) In clinical practice, The duration of the P wave in the signal.averaged 
electrocardiogram (pSAECG) has b~en oso¢~ to identify pta at risk for AF, but 
Its valise In hyportonelvo heart dlsoaso h~a not been apeclrma!ly e~essed, 
Methods: We compared the diagnostic performance (ROC cgw~a) of the 
t01t etfl~tl (LA) ol=e and the DSAECG In 31 pts with hypertensive heart d i~se  
(18 with a histow o! AF), The pSAECG was ~¢orqecl in orthogonal XY~ leads 
with Marquette Etoctronies, Ino, software, 
Respite: Beth tests identified pts with AF, hot the overall pertom~ance of 
LA ei~o wan eupedor (~rea ondor the RC~ e~n/e 0,81 vs  0,70; 2.tailed p 
0,~0) The h0St CutOff Of LA ~44 mm had sensitivity e! 61% and specttclty el 
85% The boM cutoff ef hltered P wave :: 150 ms had sensilivity of 61% and 
Sp0clti~ity Of 70%, The combination of both signs had a sensitivity el 2~.  
nnd a specificity of 92% (only 1 of the 13 pie without AF had both signs). 
I- Specificity 
Conclusions: pSAECG does not appear to be particularly efficient in 
identifying hypertensives with AF. Its main clinical value may reside in its use 
in combination with other clinical markers, like LA size. 
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~-3-7--2-1 Disagreement Between Site Investigators and 
Clinical Event Committees is Common and Can 
Affect Trial Results 
K.W. Mahaftey, B.E. Tardiff, CB. Granger, K.L Lee, R.A. Harrington, 
E,J. Topoi, R,M, Califf, Duke Clinical Research Institute, Durham, NC, 
USA 
Background," A centralized Clinical Events Committee (CEC) review process 
was used to adjudicate suspected clinical endpoint events in four large. 
randomized multicenter clinical tdals. 
Methods: We compared the pdmary endpoint event rates determined by 
data on the Case Report Form (CRF) with the event rates reported by the 
CEC (see table). 
Results: The event rates reported by the CEC were typically higher than 
those rep,.rted by investigators on the CRF. The effect on the statistical 
CRF CEC 
Control Study P Control Study P 
EPIC 12.4% 9,0% 0.120 12.8% 8.3% 0.009 
IMPACT-II 7.8% 5.5% 0.018 11.4% 9.2% 0.063 
GUSTO-lib 9.6% 84% 0.016 9.8% 8,9% 0.058 
PURSUIT 10.0% 8.0% 0.0007 15.7% 14.2% 0.042 
